"ICN is committed to the research and development of biomedical drugs, and the facility allows them to maintain its commitment," said one of the brokers on the deal. Based in Costa Mesa, ICN produces drugs for research at universities, hospitals and for other drug manufacturers.
Brokers from Voit Commercial Brokerage's Anaheim Metro and Irvine offices represented both ICN and the owner, the Burnett Family Trust, on the transaction.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
